Resources

Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C

Showing 1 to 10 of 426 resources

  • United Kingdom drug situation: Focal Point annual report 2017
    The UK Focal Point on Drugs' (part of Public Health England) annual report on the United Kingdom drug situation, providing updates for 2017. The report contains details of hepatitis C prevalence and incidence rates among injecting drug users, levels of testing, diagnosis and treatment for hepatitis C and prevention efforts by UK governments.
    UK Reports & Research PDF
  • A Census of Medical Workforce & Infrastructure for Liver Disease Strategy: Summary of Findings
    As part of the National Liver Disease Strategy (NLDS), this document summarises the findings of a Census of the Medical Workforce (Consultant Gastroenterologists and Hepatologists). The census was undertaken with the aim of assessing the current capacity and infrastructure for delivery of Liver services in England, to identify which secondary care pathways already exist for referral and management, to understand how the current secondary care services relate to burden of disease, and to assess future training needs and capacity for liver services.
    England 2011 Reports & Research, Strategy & Planning PDF
  • A glossary of contested terms in substance use
    This is a glossary of terms used by people working in the drugs field, drawn up by the Scottish Drugs Forum. It covers some of the specialised and contentious language used in the field. We have included it in the resource library as it may be helpful to those who work in health services who are less familiar with some of the language and terms used by colleagues and partners in drug services.
    UK 07 Oct 2020 Training, Reports & Research PDF
  • A Matter of Chance: An Audit of Hepatitis C Healthcare in England
    In February 2006, more than 18 months after the launch of the Department of Health's 2004 Action Plan for Hepatitis C setting out required actions for Primary Care Trusts (PCTs) and NHS Hospital Trusts, the All-Party Parliamentary Hepatology Group undertook a survey of PCTs and NHS Hospital Trusts in order to audit what actions they had taken to fulfil the Action Plan’s stated requirements. 'A Matter of Chance' reports on the findings of this research.
    UK May 2006 Reports & Research PDF
  • Peer-based needle exchange service in London
    A peer-based needle exchange service in London
    Funded by Hackney Council as part of the ADDER (addiction, diversion, disruption, enforcement and recovery) Accelerator project, the London Joint Working Group on Substance Use and Hepatitis C (LJWG) have a released a report exploring the feasibility, acceptability, and practical considerations of developing a peer-based needle exchange service. It draws on focus groups with people who use needle exchange services and peer support workers, interviews with experts from services and commissioning bodies, and international evidence.
    Greater London 18 Jan 2022 Reports & Research PDF
  • A Time to Act: Improving Liver Health and Outcomes in Liver Disease
    This document reviews the current landscape of UK liver disease and advises the Department of Health on ways to improve liver services and the outcomes of liver disease in the UK. It stresses the fact that radical change in the profile of the disease is achievable, and includes recommendations on cost-effective and high quality management of liver disease and liver services, the establishment of training frameworks and the setting of clinical standards, quality metrics and guidelines for the monitoring and assessment of local services.
    UK 2009 Reports & Research, Strategy & Planning PDF
  • Access and Uptake of Direct Acting Antiviral Medicines in the UK and selected European countries
    This report, produced by IMS Health and commissioned by the Association of the British Pharmaceutical Industry (ABPI), provides information related to the uptake of Direct Acting Antiviral treatments (DAAs) over the last five years, to June 2016. The intention of the report is to benchmark the UK – in relation to patient access to these medicines – compared with other European countries. It finds that there have been significant variances in the ability of patients to access these medicines.
    UK Feb 2017 Reports & Research PDF
  • Action Plan for the Prevention, Management and Control of Hepatitis C in Northern Ireland
    The actions set out in this report form the core of a plan to address hepatitis C in Northern Ireland for the period 2006-2008. Its aim is to achieve a reduction in the transmission of hepatitis C in Northern Ireland and to ensure that people with hepatitis C infection are identified and receive high quality, evidence-based, patient-focused treatment and care.
    Northern Ireland Jan 2007 Reports & Research, Strategy & Planning PDF
  • Addaction Hepatitis C Strategy
    Substance misuse service Addaction has produced a Hepatitis C Strategy, detailing the service's five-point plan for contributing to efforts to tackle hepatitis C.
    UK Strategy & Planning PDF
  • Addressing hepatitis C in prisons and other places of detention
    Addressing hepatitis C in prisons and other places of detention

    A report from The Hepatitis C Trust providing recommendations for hepatitis C healthcare service in prisons and other detention settings in the UK.

    UK May 2013 Reports & Research PDF

Pages